Insider Trading July 7, 2026 07:09 PM

Ultra Clean Holdings Executive Offloads Shares Under Pre-Arranged Plan

CAO Brian Harding's $494,019 sale comes amid strong Q1 earnings and analyst upgrades, though the stock has recently retreated from its highs.

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
UCTT

Brian E. Harding, the Chief Accounting Officer at Ultra Clean Holdings, Inc. (NASDAQ: UCTT), executed a series of stock sales totaling 3,837 shares on July 2, 2026. The transactions, valued at approximately $494,019, were conducted under a pre-arranged Rule 10b5-1 trading plan established earlier in the year. While the executive's sale reduces his direct holdings to 33,581 shares, the company's recent financial performance and analyst sentiment present a complex picture for investors. Ultra Clean reported first-quarter 2026 results that surpassed market expectations, yet its shares have experienced significant volatility, including a sharp recent decline despite a strong annual return.

Ultra Clean Holdings Executive Offloads Shares Under Pre-Arranged Plan
UCTT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Ultra Clean Holdings Q1 2026 earnings of $0.31 per share and revenue of $533.7 million exceeded analyst forecasts, highlighting strong operational performance in the semiconductor equipment sector.
  • Analyst sentiment has turned positive, with Needham raising its price target to $92 and UBS initiating coverage with a Buy rating and a $130.00 target, citing strong margins and the company's critical role in the semiconductor supply chain.
  • Executive insider activity, specifically the sale of 3,837 shares by CAO Brian Harding under a Rule 10b5-1 plan, reduces his direct holdings to 33,581 shares, occurring amidst significant stock price volatility.

Brian E. Harding, serving as the Chief Accounting Officer for Ultra Clean Holdings, Inc. (NASDAQ: UCTT), has completed a series of stock transactions resulting in the sale of 3,837 shares of the company's common stock. The aggregate value of these sales was reported at approximately $494,019. The transactions were executed on July 2, 2026, with the share prices varying between $126.9161 and $130.1235 during the execution period. This executive activity occurs against a backdrop of notable price movement for UCTT, which has seen its value drop to $90.78 following a 36% decline over the preceding week. Despite this recent downward pressure, the stock has maintained a substantial 276% return over the past twelve months.

According to analysis from InvestingPro, which provides detailed Pro Research Reports for more than 1,400 US equities, the current valuation of Ultra Clean Holdings appears undervalued relative to its fundamentals. The recent sales by Mr. Harding were not ad-hoc but were governed by a pre-arranged Rule 10b5-1 trading plan that was adopted on March 5, 2026. This plan facilitated the liquidation of shares across multiple price points, breaking down the total transaction volume as follows:

  • 440 shares were liquidated at a weighted average price of $126.9161, with individual sale prices ranging from $126.3500 to $127.1650.
  • An additional 2,194 shares were sold at a weighted average price of $128.3673, with individual sale prices ranging from $127.5050 to $128.5000.
  • A final block of 1,203 shares was disposed of at a weighted average price of $130.1235, with individual sale prices ranging from $129.5900 to $130.2400.

Following the completion of these transactions, Mr. Harding's direct ownership of Ultra Clean Holdings common stock stands at 33,581 shares. The executive's activity is set against a backdrop of strong corporate performance and shifting analyst sentiment. Ultra Clean Holdings reported financial results for the first quarter of 2026 that exceeded consensus expectations. The company posted earnings per share of $0.31, beating the forecasted $0.26, and generated revenue of $533.7 million, surpassing the anticipated $525.28 million. Despite these positive financial metrics, the stock experienced a decline during after-hours trading following the earnings release.

Analyst coverage has also shifted positively. Needham raised its price target for Ultra Clean Holdings from $70 to $92, while maintaining a Buy rating. The firm cited strong revenue growth and non-GAAP gross margins that exceeded expectations, attributing this margin strength to higher volumes and a more favorable product mix. Additionally, UBS initiated coverage of the company with a Buy rating and set a price target of $130.00. UBS highlighted Ultra Clean's role as a key supplier to major semiconductor equipment makers, indicating a positive outlook on the company's performance and market position.

The stock's recent price action shows significant volatility. As of the latest close, UCTT traded at $90.78, down $14.75 or 13.98%. After-hours trading saw further movement, with the stock at $90.00, down $0.78 or 0.86%. This volatility underscores the dynamic nature of the semiconductor equipment sector, where supply chain dynamics and execution risks can drive sharp price adjustments. The divergence between strong analyst fundamentals and recent price weakness presents a complex environment for investors tracking insider activity and corporate performance.

Risks

  • Despite positive earnings and analyst upgrades, the stock experienced a decline during after-hours trading and a 36% drop over the past week, indicating potential short-term volatility and market sensitivity to semiconductor sector fluctuations.
  • The sharp recent decline in share price to $90.78, down from recent highs, highlights the risk of rapid valuation adjustments in the specialized chemicals and semiconductor equipment markets, even for companies with strong fundamentals.
  • The reliance on major semiconductor equipment makers as key customers introduces specific supply chain and demand risks that could impact Ultra Clean's performance, as noted by UBS in their coverage initiation.

More from Insider Trading

CrowdStrike CEO George Kurtz Executes $3.98 Million Stock Sale Under Pre-Arranged Plan Jul 7, 2026 Palantir CTO Sankar Shyam Executes $24 Million Share Disposition Amid Strategic Expansion Jul 7, 2026 Kymera Therapeutics CEO Mainolfi Executes $5.95M Stock Sale Under Pre-Arranged Plan Jul 7, 2026 Damora Therapeutics Executive Offloads Shares Following RSU Vesting Jul 7, 2026 Circle8 Group Chairman and CEO Franke Divests Shares in Automated Transaction Jul 7, 2026